European Committee Recommends Approval of Irbesartan for Diabetic Renal Disease
PARIS, FRANCE and PRINCETON, NJ — March 12, 2002 — Sanofi-Synthélabo and Bristol-Myers Squibb Company announced today that the European Committee for Proprietary Medicinal Products




